Atomwise to collaborate with Hansoh Pharma for AI-based drug discovery
Date: 2019-09-14   Author: Pankaj Singh  Category: #news

Atomwise to collaborate with Hansoh Pharma for AI-based drug discovery

Atomwise Inc., a leading developer of healthcare software that uses AI to discover medicines and agricultural compounds, recently announced that it will be collaborating with Hansoh Pharmaceutical Group Company Limited, a leading Chinese biopharmaceutical company, to discover and design potential drugs for around eleven confidential target proteins in different therapeutic areas.

Dr. Abraham Heifets, CEO, Atomwise, stated that interesting scientific discoveries have been taking place in Asia and there is a tremendous potential for leadership in the field of innovative drug discovery.  Hansoh Pharma is the company’s first partner in Asia.

Dr. Heifets further commented that Hansoh Pharma has been committed towards innovation and shares the company’s goal to have a global impact on the health of the patients.

Apparently, scientific teams from Hansoh Pharma and Atomwise will be collaborating closely on the programs. The combination of Atomwise’s medicinal chemistry, protein structure expertise and AI technologies and Hansoh Pharma’s manufacturing, commercial capabilities and fully integrated research and development has the potential to compress timelines and dramatically increase success for clinical development and drug discovery.

As per the terms of the collaboration, Atomwise will be receiving option exercise fees, confidential technology access fees, royalties and asset sale under collaboration or income based on sublicensing. Considering the historical average revenues generated from small molecule drugs, it has been estimated that the potential value of the collaboration deal is projected to reach US$1.5 billion.

Atomwise Inc., had invented the first learning AI technology for the discovery of structure-based small molecule drug. Atomwise was created in 2012 and performs tons of projects every year partnering with the world’s largest agrochemical and pharmaceutical companies along with more than hundred hospitals and universities in about 19 countries.

The company has raised more than $50 million from some leading venture capital enterprises to encourage and support the application and development of its AI technology.

Source Credit- https://www.businesswire.com/news/home/20190911005824/en/Atomwise-Announces-Largest-China-US-Collaboration-AI-Drug



About Author


Pankaj Singh

Pankaj Singh

Pankaj Singh Develops content for Algosonline, Market Size Forecasters, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More from Pankaj


Post Recommendents

Global Online Trading Platform Market - Detailed Analysis of Current Industry Figures with Forecasts Growth By 2026
Author: Ashwin Naphade

The ' Online Trading Platform market' study recently added by Market Study Report, LLC, offers an in-depth analysis of the current market trends influencing this business vertical. The study also includes market valuation, market size, rev...


Digital Banking Platform and Services Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2026
Author: Ashwin Naphade

The ' Digital Banking Platform and Services market' study now available with Market Study Report, LLC, delivers a concise outlook of the powerful trends driving market growth. This report also includes valuable information pertaining to market sha...


Marine Fleet Management Software Market Overview, Industry Top Manufactures, Size, Growth rate 2020 ? 2026
Author: Ashwin Naphade

Market Study Report, LLC, has added a research study on ' Marine Fleet Management Software market' which extends an in-depth analysis of the potential factors fueling the revenue landscape of this industry. The study also comprises valuable insigh...